SCHEMBL7328631

SCHEMBL7328631

COc1ccc(-c2ccc(C=NO)o2)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.56
KDM4E B2RXH2 4/20 0.56
HPGD P15428 5/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
HTT P42858 2/20 0.50
HTRA2 O43464 1/20 0.50
GFER P55789 1/20 0.50
GCGR P47871 1/20 0.49
PDE4A P27815 1/20 0.46
CACNA1G O43497 1/20 0.46
CACNA1B Q00975 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.45
CYP2A6 P11509 3/20 0.44
CYP3A4 P08684 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328626 1.00 MAPT (0.56) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL11252888 0.87 PDE4A (0.63) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL11710905 0.87 PDE4A (0.63) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL11252892 0.87 PDE4A (0.63) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL1116276 0.82 HTRA2 (0.56) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL7330422 0.81 KDM4E (0.52) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL7330415 0.81 KDM4E (0.52) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL11778975 0.77 SMN1; SMN2 (0.63) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL11778979 0.77 SMN1; SMN2 (0.63) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL13497043 0.75 MAPT (0.67) MAPTKDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882354-A N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents NORWICH EATON PHARMACEUTICALS, INC. (US) 1989-11-21 US disclosed
EP-0321431-A1 N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents Norwich Eaton Pharmaceuticals, Inc. (US) 1989-06-21 EP disclosed